Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

STAAR Surgical Company

STAANASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 18, 2026Accepted Aug 18, 2026, 4:03 PM EDTFiling CIK 718937Accession 0001731487-26-000011
Share

Structured filing — 4

ownership.xml

Open full document ↗

Filing details

Report period
2026-08-14
Issuer
STAAR SURGICAL CO
Issuer CIK
0000718937
Trading symbol
STAA

Reporting owner 1

Name
Michna Magda
Reporting owner CIK
0001731487
Relationship
Officer
Officer title
Chief Development Officer
Address
25510 COMMERCENTRE DRIVE, LAKE FOREST, CA, 92630

Non-derivative transactions

Non-derivative transactions · 4 reported rows
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-08-14M · Form 45,499A043,599[F1]D
Common Stock2026-08-14F · Form 42,797[F2]D26.1840,802D
Common Stock2026-08-14F · Form 4559D26.1840,243D
Common Stock2026-08-14M · Form 41,100A26.1841,343D
Table key
M · Form 4
Exempt derivative exercise or conversion under Rule 16b-3
A
Acquired
D
Direct
F · Form 4
Securities delivered or withheld for exercise price or tax liability under Rule 16b-3

Derivative transactions

Derivative transactions · 2 reported rows
SecurityConversion / exercise price (USD)Transaction dateCodeAmountA / DPrice (USD)ExercisableExpiresUnderlying securityUnderlying sharesOwned afterOwnership
Performance Stock Units02026-08-14M · Form 45,499A0[F3]2027-12-31Common Stock5,4995,499D
Performance Stock Units02026-08-14M · Form 41,100A0[F4]2027-12-31Common Stock1,1001,100D
Table key
M · Form 4
Exempt derivative exercise or conversion under Rule 16b-3
A
Acquired
D
Direct

Footnotes

F1
Due to clerical errors, the Reporting Person's prior Form-4 filed with the Securities and Exchange Commission on May 12, 2026 incorrectly reported this value as 32,691 shares when the Reporting Person beneficially owned 28,008 shares and the Reporting Person's prior Form 4 filed with the SEC on May 19, 2026 incorrectly reported this value as 46,026 when the Reporting Person beneficially owned 38.100. The values have been corrected herein.↩ 1
F2
On August 14, 2026, the third tranche of 5,499 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program ("2025 PSU Program") in connection with her annual equity grant vested, of which 2,797 shares were withheld to satisfy taxes.↩ 1
F3
Represents the settlement of the third tranche of 5,499 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her annual equity grant vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.↩ 1
F4
Represents the settlement of the third tranche of of 1,100 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her promotion to Chief Development Officer vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.↩ 1

Signature 1

Signed
/s/ Magda Michna
Date
2026-08-18

Company context

STAAR Surgical (NASDAQ: STAA) is the global leader in implantable phakic intraocular lenses, a vision correction solution that reduces or eliminates the need for glasses or contact lenses. Since 1982, STAAR has been dedicated solely to ophthalmic surgery, and for over 30 years, STAAR has been designing, developing, manufacturing, and marketing advanced Implantable Collamer® Lenses (ICLs), using its proprietary biocompatible Collamer material. STAAR ICLs are clinically proven to deliver safe long-term vision correction without removing corneal tissue or the eye's natural crystalline lens. Its EVO ICL™ product line provides visual freedom through a quick, minimally invasive procedure.

Current securities

Recent company filings

  1. SCHEDULE 13G/A - filed by Point72 Asset Management, L.P. regarding STAAR SURGICAL CONov 16, 2026
  2. 10-Q filingNov 4, 2026
  3. Results of Operations and Financial Condition · Regulation FD DisclosureNov 4, 2026
  4. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureOct 5, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureSep 10, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.